The Role of Tracheotomy and Timing of Weaning and Decannulation in Patients Affected by Severe COVID-19.


Journal

Ear, nose, & throat journal
ISSN: 1942-7522
Titre abrégé: Ear Nose Throat J
Pays: United States
ID NLM: 7701817

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 10 10 2020
medline: 12 3 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Patients with acute respiratory failure due to coronavirus disease 2019 (COVID-19) have a high likelihood of needing prolonged intubation and may subsequently require tracheotomy. Indications and timing for performing tracheotomy in patients affected by severe COVID-19 pneumonia are still elusive. The aim of this study is to analyze the role of tracheotomy in the context of this pandemic. Moreover, we report the timing of the procedure and the time needed to complete weaning and decannulation in our center. This retrospective, observational cohort study included adults (≥18 years) with severe COVID-19 pneumonia who were admitted to the intensive care unit (ICU) of the tertiary care center of Reggio Emilia (Italy). All patients underwent orotracheal intubation with invasive mechanical ventilation, followed by percutaneous or open surgical tracheotomy. Indications, timing of the procedure, and time needed to complete weaning and decannulation were reported. Forty-four patients were included in the analysis. Median time from orotracheal intubation to surgery was 7 (range 2-17) days. Fifteen (34.1%) patients died during the follow-up period (median 22 days, range 8-68) after the intubation. Weaning from the ventilator was first attempted on median 25th day (range 13-43) from orotracheal intubation. A median of 35 (range 18-79) days was required to complete weaning. Median duration of ICU stay was 22 (range 10-67) days. Mean decannulation time was 36 (range 10-77) days from surgery. Since it is not possible to establish an optimal timing for performing tracheotomy, decision-making should be made on case-by-case basis. It should be adapted to the context of the pandemic, taking into account the availability of intensive care resources, potential risks for health care workers, and benefits for the individual patient.

Identifiants

pubmed: 33035129
doi: 10.1177/0145561320965196
pmc: PMC7548540
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

116S-119S

Auteurs

Cecilia Botti (C)

PhD Program in Clinical and Experimental Medicine, 208968University of Modena and Reggio Emilia, Reggio Emilia, Italy.
Otolaryngology Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Francesca Lusetti (F)

Otolaryngology Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Stefano Peroni (S)

Intensive Care Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Tommaso Neri (T)

Intensive Care Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Andrea Castellucci (A)

Otolaryngology Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Pierpaolo Salsi (P)

Intensive Care Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Angelo Ghidini (A)

Otolaryngology Unit, 9242Azienda USL-IRCCS, di Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH